SV Life Sciences expands team with new hires
SV Life Sciences has hired Dan Burgess, Dr. Ed Mascioli and Dr. Michael Mendelsohn as new venture partners. Burgess was the founder, president and CEO of Rempex Pharmaceuticals while Mascioli was the CEO of Affinium Pharmaceuticals. And, previously, Mendelsohn worked at Merck Research Laboratories where he served as senior vice president and global franchise head, cardiovascular diseases.
2 June 2014•4 mins read
